Avalo Therapeutics, Inc. AVTX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

43/100

3/7 Pass

SharesGrow Intrinsic Value

총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Avalo Therapeutics, Inc. (AVTX), 포함 29 건 매수 및 17 건 매도. 내부자 매수 총액은 $18.97M 내부자 매도 총액은 $848.54K.

최근 활동이 있는 주요 내부자에는 Sullivan Christopher Ryan, Doyle Mittie, Lind Kevin Robert. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — AVTX

날짜	이름	직책	거래 유형	주식수	평균 가격	금액	보유 주식수
2026-04-02	Sullivan Christopher Ryan	Chief Financial Officer	정보 매도	1,780	$17.57	$31.27K	17,338
2026-04-01	Sullivan Christopher Ryan	Chief Financial Officer	정보 매도	7,479	$16.83	$125.84K	25,318
2026-04-01	Doyle Mittie	Chief Medical Officer	정보 매도	679	$16.00	$10.86K	3,622
2026-03-31	Lind Kevin Robert	Director	RSU 부여	1,370	$14.93	$20.45K	1,370
2026-03-31	Jain Rita	Director	RSU 부여	1,339	$14.93	$19.99K	1,339
2026-03-28	Kaplan Gilla	Director	옵션 행사 (매도)	3,166	-	-	3,167
2026-03-28	Neil Garry Arthur	Chief Executive Officer	옵션 행사 (매도)	64,866	-	-	64,867
2026-03-28	Chan Mitchell	Director	옵션 행사 (매도)	3,166	-	-	3,167
2026-03-28	Sullivan Christopher Ryan	Chief Financial Officer	옵션 행사 (매도)	24,200	-	-	24,200
2026-03-28	Kantoff Aaron	Director	옵션 행사 (매도)	3,166	-	-	3,167
2026-03-28	Goldman Jonathan	Director	옵션 행사	3,166	-	-	3,166
2026-03-28	Truex Samantha	Director	옵션 행사 (매도)	3,166	-	-	3,167
2026-03-16	Doyle Mittie	Chief Medical Officer	정보 매도	25,492	$16.15	$411.61K	3,622
2026-02-26	Neil Garry Arthur	Chief Executive Officer	RSU 부여	286,000	$17.64	$5.05M	286,000
2026-02-26	Varki Paul	Chief Legal Officer	RSU 부여	80,000	$17.64	$1.41M	80,000
2026-02-26	Sullivan Christopher Ryan	Chief Financial Officer	RSU 부여	105,000	$17.64	$1.85M	105,000
2026-02-26	Doyle Mittie	Chief Medical Officer	RSU 부여	105,000	$17.64	$1.85M	105,000
2026-02-26	Riley Jennifer	Chief Strategy Officer	RSU 부여	95,000	$17.64	$1.68M	95,000
2026-02-26	Boyd Taylor	Chief Business Officer	RSU 부여	95,000	$17.64	$1.68M	95,000
2025-12-31	Lind Kevin Robert	Director	RSU 부여	848	$18.16	$15.4K	848
2025-12-31	Jain Rita	Director	RSU 부여	1,043	$18.16	$18.94K	1,043
2025-12-10	Varki Paul	Chief Legal Officer	RSU 원천징수	1,016	$4.10	$4.17K	3,634
2025-12-10	Sullivan Christopher Ryan	Chief Financial Officer	RSU 원천징수	155	$4.10	$635.50	17,338
2025-12-10	Doyle Mittie	Chief Medical Officer	RSU 원천징수	1,013	$4.10	$4.15K	3,622
2025-12-10	Riley Jennifer	Chief Strategy Officer	RSU 원천징수	637	$4.10	$2.61K	2,655
2025-11-14	Goldman Jonathan	Director	정보 매도	3,167	$14.30	$45.29K	-
2025-10-01	Lind Kevin Robert	Director	알 수 없음	-	-	-	-
2025-10-01	Lind Kevin Robert	Director	RSU 부여	40,200	$12.96	$520.99K	40,200
2025-10-01	Boyd Taylor	Officer	알 수 없음	-	-	-	-
2025-10-01	Boyd Taylor	Chief Business Officer	RSU 부여	275,000	$12.96	$3.56M	275,000
2025-09-30	Jain Rita	Director	RSU 부여	1,572	$12.71	$19.98K	1,572
2025-06-17	Kaplan Gilla	Director	RSU 부여	20,100	$4.47	$89.85K	20,100
2025-06-17	Heffernan Michael Thomas	Director	RSU 부여	29,500	$4.47	$131.87K	29,500
2025-06-17	Almenoff June Sherie	Director	RSU 부여	20,100	$4.47	$89.85K	20,100
2025-06-17	Jain Rita	Director	알 수 없음	-	-	-	-
2025-06-17	Jain Rita	Director	RSU 부여	40,200	$4.47	$179.69K	40,200
2025-06-17	Chan Mitchell	Director	RSU 부여	20,100	$4.47	$89.85K	20,100
2025-06-17	Kantoff Aaron	Director	RSU 부여	20,100	$4.47	$89.85K	20,100
2025-06-17	Goldman Jonathan	Director	RSU 부여	20,100	$4.47	$89.85K	20,100
2025-06-17	Truex Samantha	Director	RSU 부여	20,100	$4.47	$89.85K	20,100
2025-03-28	Kaplan Gilla	Director	옵션 행사	3,167	-	-	3,167
2025-03-28	Almenoff June Sherie	Director	옵션 행사	3,167	-	-	3,167
2025-03-28	Neil Garry Arthur	Chief Executive Officer	RSU 원천징수	17,787	$8.46	$150.48K	47,140
2025-03-28	Chan Mitchell	Director	옵션 행사	3,167	-	-	3,167
2025-03-28	Sullivan Christopher Ryan	Chief Financial Officer	RSU 원천징수	7,285	$8.46	$61.63K	16,921
2025-03-28	Kantoff Aaron	Director	옵션 행사	3,167	-	-	3,167
2025-03-28	Goldman Jonathan	Director	옵션 행사	3,167	-	-	3,167
2025-03-28	Truex Samantha	Director	옵션 행사	3,167	-	-	3,167
2025-03-25	Heffernan Michael Thomas	Director	알 수 없음	-	-	-	-
2025-03-25	Heffernan Michael Thomas	Director	RSU 부여	50,000	$8.54	$427K	50,000